| 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -2,2 k € | +38.9% | -3,6 k € | -88.5% | -1,9 k € | -3.5% | -1,9 k € | -11.0% | -1,7 k € | -4.5% | -1,6 k € | -6.0% | -1,5 k € | -7.4% | -1,4 k € | -2.9% | -1,4 k € | -3.0% | -1,3 k € | -2.3% | -1,3 k € | — | ||
| EBITDA | -3,9 k € | +38.5% | -6,3 k € | -81.8% | -3,5 k € | -4.8% | -3,3 k € | -6.8% | -3,1 k € | +0.9% | -3,1 k € | -2.1% | -3,0 k € | -2.4% | -3,0 k € | -1.7% | -2,9 k € | -6.7% | -2,7 k € | -18.3% | -2,3 k € | -111.3% | -1,1 k € | |
| Operating profit | -3,9 k € | +38.5% | -6,3 k € | -81.8% | -3,5 k € | -4.8% | -3,3 k € | -6.8% | -3,1 k € | +0.9% | -3,1 k € | -2.1% | -3,0 k € | -2.4% | -3,0 k € | -1.7% | -2,9 k € | -6.7% | -2,7 k € | -18.3% | -2,3 k € | +52.9% | -4,9 k € | |
| Profit/loss | -39,1 k € | +3.5% | -40,5 k € | -10.9% | -36,5 k € | -3.4% | -35,3 k € | -8.0% | -32,7 k € | -2.9% | -31,8 k € | -2.5% | -31,0 k € | -3.7% | -29,9 k € | -3.2% | -28,9 k € | -5.1% | -27,5 k € | -15.9% | -23,8 k € | +3.5% | -24,6 k € | |
| Equity | 2,1 M € | -1.8% | 2,1 M € | -1.9% | 2,2 M € | -1.6% | 2,2 M € | -3.0% | 2,3 M € | -1.4% | 2,3 M € | -1.4% | 2,3 M € | -1.3% | 2,4 M € | -1.2% | 2,4 M € | -1.2% | 2,4 M € | -1.1% | 2,5 M € | -1.0% | 2,5 M € | |
| Total assets | 3,4 M € | +0.0% | 3,4 M € | -0.0% | 3,4 M € | -0.0% | 3,4 M € | -0.0% | 3,4 M € | 0.0% | 3,4 M € | 0.0% | 3,4 M € | -0.0% | 3,4 M € | -0.0% | 3,4 M € | -0.0% | 3,4 M € | -8.1% | 3,7 M € | -0.1% | 3,7 M € | |
| Cash | 448,4 € | 0,0 € | -100.0% | 33,0 € | -62.8% | 88,7 € | -30.0% | 126,7 € | 0.0% | 126,7 € | 0.0% | 126,7 € | -65.1% | 363,1 € | -14.0% | 422,0 € | -0.7% | 425,1 € | -11.4% | 480,0 € | -27.1% | 658,0 € | ||
| Debts | 1,3 M € | +3.1% | 1,3 M € | +3.3% | 1,2 M € | +3.1% | 1,2 M € | +6.2% | 1,1 M € | +3.0% | 1,1 M € | +3.0% | 1,1 M € | +3.0% | 1,0 M € | +3.0% | 991,1 k € | +3.0% | 962,2 k € | +15.3% | 834,7 k € | +17.0% | 713,6 k € | |
Private limited company · Temse · incorporated on 21/10/2011
Private limited company loss-making in the latest fiscal year.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Excent Tandtechniek België is a Private limited company incorporated in 2011. Its registered office is in Temse.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette